Поновлено подачу документів до Держлікслужби через електронні послуги

Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…

Within 7 days, the Polish regulatory authority inspected Farmak’s production for compliance with the requirements of Good Manufacturing Practice (GMP) of the European Union. As a result, the company received…